Shares of Core Laboratories Inc. (NYSE:CLB – Get Free Report) have earned a consensus recommendation of “Reduce” from the four ratings firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating and two have issued a hold rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $18.50.
CLB has been the topic of several recent analyst reports. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research report on Friday, July 26th. Piper Sandler dropped their target price on Core Laboratories from $18.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday, July 15th. Stifel Nicolaus upped their price objective on Core Laboratories from $18.00 to $22.00 and gave the company a “hold” rating in a report on Friday, July 26th. Finally, Bank of America lowered their price target on Core Laboratories from $16.00 to $15.00 and set an “underperform” rating for the company in a report on Monday, July 15th.
Get Our Latest Analysis on Core Laboratories
Hedge Funds Weigh In On Core Laboratories
Core Laboratories Price Performance
NYSE:CLB opened at $18.33 on Friday. The company has a quick ratio of 1.68, a current ratio of 2.39 and a debt-to-equity ratio of 0.60. Core Laboratories has a 52-week low of $13.82 and a 52-week high of $26.49. The firm has a market cap of $859.68 million, a P/E ratio of 20.83, a PEG ratio of 1.47 and a beta of 2.41. The business’s 50-day moving average price is $20.79 and its 200 day moving average price is $18.07.
Core Laboratories (NYSE:CLB – Get Free Report) last announced its quarterly earnings results on Wednesday, July 24th. The oil and gas company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.01. The business had revenue of $130.58 million during the quarter, compared to analyst estimates of $132.85 million. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The firm’s revenue was up 2.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.23 EPS. As a group, sell-side analysts predict that Core Laboratories will post 0.71 earnings per share for the current fiscal year.
Core Laboratories Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 26th. Stockholders of record on Monday, August 5th will be given a $0.01 dividend. The ex-dividend date of this dividend is Monday, August 5th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.22%. Core Laboratories’s payout ratio is 4.55%.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Further Reading
- Five stocks we like better than Core Laboratories
- Stock Average Calculator
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- EV Stocks and How to Profit from Them
- Lowe’s Stock: Hold Now, Buy it When it Dips
- The 3 Best Blue-Chip Stocks to Buy Now
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.